Germany looks for cases but finds no evidence of vCJD (variant Creutzfeldt-Jakob disease)
This article was originally published in Clinica
Executive Summary
As the number of cases of bovine spongiform encephalopathy (BSE) rise in cattle in Germany, questions have arisen as to whether the country may be missing or even concealing possible cases of variant CJD (vCJD) - the form of the disease that affects humans. Officially the country has no recorded cases of the disease.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.